Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05142787
NA

Magseed Pro(R)/ Sentimag(R) Gen3

Sponsor: Endomagnetics Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is to provide prospective evidence that the Magseed Pro® marker /Sentimag® Gen3 system is safe and effective for marking A. suspicious/biopsy-proven positive axillary lymph nodes; and B. soft tissue lesions including cancer and pre-cancerous change in the breast

Official title: A Prospective, Multi Center, International, Open Label Study of the Use of Magseed Pro(R) Markers and Sentimag(R) Gen3 to Localize Breast Lesions and Suspicious/biopsy-proven Positive Lymph Nodes in Breast Cancer Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

224

Start Date

2023-03-02

Completion Date

2026-06-30

Last Updated

2024-09-19

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics

placement of Magseed Pro \& localisation with Sentimag Gen3 in axillary lymph nodes and/or breast lesions

Locations (6)

Marienhospital Bottrop GmbH

Bottrop, Germany

AGAPLESION Markus Frankfurter Diakonie Kliniken gGmbH

Frankfurt, Germany

Technical University Munich

Munich, Germany

Guy's Hospital

London, United Kingdom

Royal Marsden Hospital

London, United Kingdom

University Hospital South Manchester

Manchester, United Kingdom